The field of molecular medicine covers the medical interventions targeting molecular structures and mechanisms that are involved in disease progression.

In cancer, several molecular mechanisms have been shown to impact its progression, aggressiveness and chemoresistance. Increasing evidence demonstrates the role of nanotechnology and outcome of molecular therapy.

Several books have discussed molecular biology and mechanisms involved in cancer, but this text gives an account of molecular therapeutics in cancer relating to advancements of nanotechnology. It provides a description of the multidisciplinary field of molecular medicines and its targeted delivery to cancer using nanotechnology.

Key Features:

• Provides current information in the multidisciplinary field of molecular medicines and its targeted delivery to cancer using nanotechnology
• Presents important aspects of nanotechnology in the site-specific delivery of anticancer agents
• Includes up to date information on oligonucleotide and gene based therapies in cancer
• Describes small targeted molecules, antibodies and oligonucleotides which have shown to selectively target the molecular structures thereby influencing signal transduction
• Facilitates discussion between researchers involved in cancer therapy and nanoscientists